Entero Healthcare Solutions rose1.87% to Rs 1,113.80 after the company reported 96% surge in net profit to Rs 6.77 crore in Q3 FY24 as mpared with Rs 3.31 core in Q3 FY23.
Revenue from operations Rs 992.6 crore in Q3 FY24 as compared with Rs 829.02 crore posted in corresponding quarter last year.Profit before tax stood at Rs 8.23 crore in Q3 FY24, steeply higher than Rs 2.48 crore posted in Q3 FY23.
During the quarter, EBITDA jumped 54% to Rs 28.6 crore as compared with Rs 18.6 crore in Q3 FY23. EBITDA margin expanded by 64 bps to 2.9% in Q3 FY24 as against 2.2% in Q3 FY23.
Meanwhile, the company will acquire balance 12,00,000 equity shares (representing 15% paid up equity share capital) from erstwhile promoters of Getwell Medicare Solution Private and thereby making Getwell a wholly-owned subsidiary of the company.
The company will acquire 15% stake for total consideration of Rs 120 crore.
Prabhat Agrawal, promoter, managing director and CEO, said, delivering strong results as we capitalize on the differentiated value proposition that we bring to our customers as well healthcare product companies in this extremely fragmented supply chain market.
As we look ahead to the rest of our fiscal year, we are focused on executing on our growth levers and capturing multiple opportunities through our wide geographic network, technology driven approach and strong execution team.
With our current robust balance sheet post IPO we are well-positioned to expand our business, capitalize on future growth opportunities and continue to add value to the entire healthcare ecosystem. We are confident that our experienced and capable management team, coupled with our differentiated business model and robust strategies, will drive sustainable growth and create long-term value for our shareholders."
The shares of Entero Healthcare Solutions were listed on bourses at Rs 1,245, exhibiting a discount of 1.03% to the issue price of Rs 1,258.
Entero Healthcare Solutions is a distributor of healthcare products in India. The companys technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
